当前位置: 首页 > 详情页

The association of the regulatory region of the presenilin-2 gene with Alzheimer's disease in the Northern Han Chinese population

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China [2]Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing 100053, China
出处:
ISSN:

关键词: presenilin-2 promoter polymorphism Alzheimer's disease susceptibility case-control study

摘要:
Presenilin-2 is one of the causative genes for familial Alzheimer's disease (FAD). Polymorphism of the promoter region of the presenilin-2 gene (PSEN2) has recently been reported in a Russian population to be associated with sporadic Alzheimer's disease (SAD). The purpose of this case-control study was to determine whether SAD is associated with the PSEN2 gene polymorphism in a Chinese population. We examined PSEN2 and APOE genotypes in 200 SAD patients and an equal number of age- and sex-matched controls from the same community, using the PCR-RFLP method. Allelic and genotypic distributions were performed using the Pearson Chi-square test for homogeneity. The interactions between variables were examined by logistic regression. The results revealed no significant differences in the frequency of the +A/-A polymorphism between AD and controls (X-2 -3.857, p=0.145). However, in the subgroup of APOE epsilon 4 noncarriers, there were significant differences in the distributions of both alleles (X-2 = 6.095, p = 0.047) and genotypes (X-2 4.433, p=0.035) of the PSEN2 promoter in AD compared with controls. In APOE e4 non-carrier group, with +A/+A as a reference, the -A/-A genotype was associated with a 4.657-fold increased risk for AD (X-2 =5.783, p=0.016, OR=4.657, 95% CI= 1.195-18.152). Using logistic analysis, there were no statistical interactions between PSEN2 and APOE genotypes, or between PSEN2 genotypes and age of onset. It is concluded that in the Northern Han Chinese population, the +A/-A polymorphism of the PSEN2 promoter is a moderate genetic risk factor for developing SAD, independent of the APOE e4 allele. (C) 2007 Elsevier B.V All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2007]版:
大类 | 3 区 医学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 神经科学
JCR分区:
出版当年[2006]版:
Q2 CLINICAL NEUROLOGY Q3 NEUROSCIENCES
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China [2]Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing 100053, China
通讯作者:
通讯机构: [1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院